Drug Shortage Report for ONDANSETRON INJECTION, USP
| Report ID | 4083 |
| Drug Identification Number | 02390019 |
| Brand name | ONDANSETRON INJECTION, USP |
| Common or Proper name | Ondansetron |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ONDANSETRON |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 2ML 5VL |
| ATC code | A04AA |
| ATC description | ANTIEMETICS AND ANTINAUSEANTS |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2017-05-10 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2017-05-01 |
| Shortage status | Avoided shortage |
| Updated date | 2017-05-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2017-05-03 | French | Compare |
| v4 | 2017-05-03 | English | Compare |
| v3 | 2017-05-03 | English | Compare |
| v2 | 2017-03-23 | French | Compare |
| v1 | 2017-03-23 | English | Compare |
Showing 1 to 5 of 5